logo

For the Inventor, By the Inventor

Ober-Ramstadt, Germany

Klaus-Otto Minck

This inventor holds 51 USPTO granted patents, primarily in Pharmaceutical Chemistry (CPC class 5143). Top assignees: Merck Patent Gesellschaft MIT Beschrankter Haftung, Merck Patent Gesellschaft MIT Beschraenkter Haftung, Merck Patent Gmbh. Active years: 1980-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Klaus-Otto Minck. Retrieved from https://idiyas.com/inventor/klaus-otto-minck

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 51

% Patents Active = 100.0

Average Co-Inventor Count = 4.9

ph-index = 11

Forward Citations = 500(Granted Patents)

Forward Citations (Not Self Cited) = 476(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Darmstadt, DE (1980)
  • Ober-Ramstadt, DE (1984 - 2000)

Company Filing History:

goldMedal47 out of 1,248 
 
Merck Patent Gesellschaft MIT Beschrankter Haftung
 patents
silverMedal3 out of 100 
 
Merck Patent Gesellschaft MIT Beschraenkter Haftung
 patents
bronzeMedal1 out of 3,031 
 
Merck Patent Gmbh
 patents

Years Active: 1980-2000

Loading Chart...
Areas of Expertise:
Imidazopyridines
Benzoylguanidines
Heterocyclic Compounds
Piperidines
Thiadiazinones
Indole Derivatives
Amino Acid Derivatives
Oxazolidinones
Fluorine-Containing Compounds
Pharmaceutical Agents
Antagonists
Renin Inhibition
51 patents (USPTO):Explore Patents
1. 6037349 - Imidazopyridines (2000-03-14),
2. 6028069 - Heterocyclyl-condensed benzoylguanidines, their production and use as (2000-02-22),
3. 5849796 - Ortho-substituted benzoil acid derivatives (1998-12-15),
4. 5840761 - Alkylbenzoylguanidine derivatives (1998-11-24),
5. 5807896 - Arylbenzoylguanidines (1998-09-15),
6. 5798364 - Imidazopyridines (1998-08-25),
7. 5753680 - Heterocyclyl-benzoylguanidines (1998-05-19),
8. 5747539 - Fluorine-containing benzoylguanidines (1998-05-05),
9. 5744641 - Sulfonyl- or sulfinylbenzoylguanidine derivatives (1998-04-28),
10. 5739142 - 4-aminobenzoylguanidine derivatives (1998-04-14),
11. 5731351 - Alkenyl-benzoylguanidine derivatives (1998-03-24),
12. 5705497 - 3-alkoxycarbonyl-thiadiazinones (1998-01-06),
13. 5700839 - Alkyl-5-methylsulfonylbenzoylguanidine derivatives (1997-12-23),
14. 5696167 - 4-mercaptobenzoylguanidine derivatives (1997-12-09),
15. 5684015 - Imidazopyridines as pharmaceutical agents (1997-11-04),

Title: Klaus-Otto Minck: A Pioneer in Pharmaceutical Innovations

Introduction

Klaus-Otto Minck, based in Ober-Ramstadt, Germany, is a renowned inventor in the pharmaceutical field. With an impressive portfolio of 51 patents, he has made significant contributions to the development of innovative drugs and treatments. His work primarily focuses on compounds that have the potential to combat various cardiovascular diseases.

Latest Patents

Among his notable patents, Minck has developed imidazopyridine derivatives and pharmacologically acceptable salts that exhibit antagonistic properties towards angiotensin II. These innovative compounds hold promise for the treatment of hypertension, aldosteronism, and cardiac insufficiency. This breakthrough reflects his commitment to enhancing therapeutic options in the realm of cardiovascular health.

Career Highlights

Throughout his career, Klaus-Otto Minck has been associated with the esteemed Merck Patent GmbH, where he has played a vital role in advancing pharmaceutical research. His extensive experience in the industry has positioned him as a key figure in the development and patenting of novel therapeutic agents.

Collaborations

Minck has collaborated with distinguished professionals, including Norbert Beier and Dieter Dorsch, further emphasizing the collaborative nature of advancements in pharmaceutical innovations. These partnerships have allowed for a cross-pollination of ideas and expertise, leading to more robust developments in drug discovery.

Conclusion

Klaus-Otto Minck stands out as a pivotal inventor whose work in pharmaceutical innovations continues to impact the healthcare sector positively. His array of patents illustrates a dedication to improving treatment options and enhancing patient outcomes, solidifying his legacy in the world of pharmaceutical sciences.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…